Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inhibitex

1994 FOUNDED
M&A STATUS
81-90 EMPLOYEES
M&A LATEST DEAL TYPE
$2.5B LATEST DEAL AMOUNT
Description

Developer of antibody based products to prevent and treat bacterial and fungal infections. The company is focused on the development of small molecule antiviral compounds, and in particular, therapies to treat shingles (herpes zoster) and chronic hepatitis C infections (HCV).

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Primary Office
  • 9005 Westside Parkway
  • Alpharetta, GA 30009
  • United States

+1 (678) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inhibitex’s full profile, request a free trial.

Inhibitex Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 13-Feb-2012 $2.5B 00000 00.00 Completed Generating Revenue/Not Profitable
7. PIPE 29-Oct-2009 0000 00000 Completed Generating Revenue/Not Profitable
6. IPO 04-Jun-2004 0000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series E) 12-Jan-2004 0000 0000 Completed Generating Revenue
4. Later Stage VC (Series D) 01-Feb-2002 0000 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 15-Jun-2000 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Jan-1998 $1.5M $2M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-1995 $500K $500K Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Inhibitex Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 20-Sep-2007 000000000000000000 0000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Inhibitex Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alliance Technology Ventures Venture Capital Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
Chicago Growth Partners PE/Buyout Minority 000 0000 000000 0
Cordova Ventures Venture Capital Minority 000 0000 000000 0
EW Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »